DOCSLIB.ORG

T Cell Selection in the Thymus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
T Cell Selection in the Thymus T cell selection in the thvmus Yujiro Tanaka, M.D. Labolatory of Molecular Immunology National Institute for Medical Research The Ridgeway Mill Hill London NW7 lAA UK Submitted in partial fulfilment of the requirements of the University College of London for the degree of Doctor of Philosophy April, 1995 ProQuest Number: 10044338 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10044338 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 T i t l e ...................................................... I Abbreviations .......................................... Ill A b s t r a c t .................................................. IV Acknowledgements ....................................... VI List of figures ......................................... VII List of tables ........................................... IX Index of contents ......................................... X Chapter 1 Introduction ................................ 1 Chapter 2 Materials and methods ..................... 18 Chapter 3 Transgenic oncogenesis ..................... 38 Chapter 4 TCR transgenic m i c e .......................... 68 Chapter 5 Positive selection of T cells .............. 79 Chapter 6 Discussion .................................. 96 R e f e r e n c e s ..............................................105 II Abbreviations aMEM a minimum essential medium /32m )8-2 microglobulin BM bone marrow bp base pairs ESA bovine serum albumin CDR complementality determining region CFU-S colony forming units of spleen CTL cytotoxic T lymphocyte DMEM Dulbecco's modified Eagle's essential medium DN double negative DNA deoxyribonucleic acid DP double positive Eats Ea/tsA58 EDTA ethylendiamine tetra-acetic acid FACS fluoresence activated cell sorter FCS fetal calf serum FTOC fetal thymic organ culture g gram(s) H2ts H-2K^/tsA58 HSA heat stable antigen Hyb hybridisation IFN-7 interferon-7 IMDM Iscove's modified Dulbecco's medium MHO major histocompatibility complex ml m i n i liter(s) Mis minor lymphocyte stimulating (antigen) mM mini molar NP nucleoprotein Ntg non-transgenic PBS phosphate buffered saline PGR polymerase chain reaction RAG recombination activating gene RNA ribonucleic acid RT reverse transcription SOS sodium dodecyl sulfate SP single positive SSC 3 M NaCl, 0.35 M sodium citrate ssDNA salmon sperm DNA TAE 40 mM Tris-acetate, 1 mM EDTA TBE 45 mM Tris-borate, 1 mM EDTA TCR T cell antigen receptor TE 10 mM Tris, 1 mM EDTA TES 10 mM Tris, 1 mM EDTA, 0.5 % SDS TM Thy-l/c-myc TNE 50 mM Tris, 100 mM NaCl, 100 mM EDTA III Abstract Expression of T cell antigen receptors (TCR) and their interaction with stromal ligands determine the fate of developing T cells in the thymus. To dissect molecular mechanisms involved in T cell selection, in vitro differentiation and selection system was developed using the thymocytes from a/3 TCR (F5) transgenic mice, thymic stromal cell lines derived from oncogene transgenic mice, and synthetic peptides presented by class I major histocompatibility complex (MHC). Chapter 3 describes mice carrying a temperature sensitive SV40 large T antigen under the control of class I H-2K^ promoter (H2ts mice). These mice develop normally except for the enlargement of the thymus in the adults. Conditionally immortalised thymic stromal cell lines were established from such hyperplastic thymic tissues. To compare antigen presentation capacities, thymic cortical epithelial cell lines and freshly isolated thymic dendritic cells were co-cultured with immature thymocytes or mature T cells from F5 TCR transgenic mice in the presence or absence of cognate peptide. The results show that cortical epithelial cells are as efficient as dendritic cells in negative selection of F5 thymocytes, but not in activating mature F5 T cells. In an attempt to establish cell lines which support positive selection of T cells, adherent cells in a thymic tumour of an H2ts mouse were purified using magnetic beads coated with antibodies against CD45, class II MHC, and a medullary epithelial marker. Several epithelial cell lines expressing class II H-2A*’ and a cortical marker ER-TR4 were established, and their function was assessed by reaggregate culture (chapter 5). Immature T cell lines were derived from mice which express c-myc proto-oncogene under the control of Thyl gene promoter (TM mice) . These mice develop thymic tumours consisting predominantly of CD4+CD8+ (DP) cells which are mono- or oligo-clonal. Overexpression of c-myc is associated with increased apoptosis of thymocytes in vivo, and DP cell lines derived from the tumours retained their abilities to undergo apoptosis upon TCR stimulation. However, it was not possible to induce differentiation of these DP cells to CD4 or CD8 single positive (SP) cells. Chapter 4 describes development of T cells in mice transgenic for an ajS TCR which was isolated from a cytotoxic clone F5 specific for a peptide from influenza nucleoprotein and class I H-2D^. Ontogeny of T cells in F5 mice is largely similar to that in normal mice for expression of CD4, CD8 , and TCR, except for slightly earlier appearance of immature CD8 SP cells and DP cells. The data suggest that expression of functional ajS TCR enhances transition from CD4CD8" (DN) to DP cells. Addition of cognate peptide in F5 fetal thymic organ culture causes severe block at the stage between immature CD8 SP and DP cells. A significant number of DP cells which develop in the presence of cognate peptide do not express F5 TCR and are likely to escape from cell death by expression of endogenous TCR since these do not appear in F5/RAG1^" thymic lobes. IV Chapter 5 describes effects of thymic stromal cell lines and peptide analogues on F5 T cell development in vitro. F5 TCR transgenic mice were bred to non-selecting MHC backgrounds such as H -24 or /3-2 microgrobulin (#2m)-deficient mice, in which T cell development was arrested at DP stage. Total thymocytes, including T cell progenitors and stromal cells expressing non­ selecting MHC, were then reaggregated with thymic cortical epithelial cell lines which express class I H-2^. The data show that development of F5^^ or F5/j82m'^" T cells can be restored by such epithelial cell lines. Further in an attempt to identify peptide/MHC ligands which mediate signals for positive selection of F5 T cells, peptide analogues were designed by introducing single amino acid substitutions in nonameric cognate peptide. The present study on F5 T cell development in fetal thymic organ culture confirms importance of side chains of residues at positions 4 and 7 of the peptide for interaction with TCR, as predicted from crystallographic data by others. Two of the peptides exhibit antagonistic activity and one of them appears to augment positive selection of F5 T cells if provided with suboptimal dose of cognate peptide. These data may imply significance of the presence of heterogeneous peptides in vivo for positive selection of T cells. V Acknowledgements I am deeply indebted to my supervisor, Dr. Dimitris Kioussis, for his continuous encouragement and consideration upon my work and life during my stay in London. I would also like to thank Mrs. Trisha Norton for her excellent helps in maintaining animals, Mr. Chris Atkins for assistance in sorting lymphocytes, and Drs. Clio Mamalaki, Elaine Dzierzak, and Brigitta Stockinger (NIMR, London), Drs. Farmjit Jat, Paris Ataliotis, Mark Noble (Ludwig Institute, London), Dr. Richard Flavell (Yale University, USA), Drs. Marry Ritter and Heather Ladyman (Hammersmith Hospital, London), Dr. Mark Bix (UCSF, USA), and Drs. Graham Anderson, Eric Jenkinson, and John Owen (Bermingam University, Bermingham) for their techinical assistance and helpful discussions. I would like to thank Dr. Eugenia Spanopoulou (New York University, New York) for kindly providing us with RAGl-deficient mice. Dr. Jaenish (MIT, USA) for /82m-deficient mice, Drs. Rose Zamoyska (NIMR), Anna Sponaas (NIMR), Kyuhei Tomonari (CRC, London), Brigitte Lane (Ludwig Institute, London), Marry Ritter (Hammersmith Hospital, London), Willem van Ewijk (Rotterdam University, Holland), and Erick Jenkinson (Bermingham) for antibodies. Dr. Paul Travers (ICRF, London) for making computer models of peptides bound to H-2D^ molecules. My special thanks go to Ms. Michel Burke for her secretarial service, and Mr. Mauro Tolaini, Drs. Paola Corbella and Richard Festenstein, and other members of Dr. Kioussis' and Dr. Frank Grosveld's laboratories for many exciting discussions and technical advice. This work was supported by grants from the Medical Research Council and the Leukaemia Research Fund. VI List of figures No. Contents Chapters 1 T cell development in the thymus 1 2 H-2K^/tsA58 transgenic mice 3.2.1 3 Northern blot analysis of tsA58 expression in H2ts mice 3.2.1 4 Histology of thymic tumours in H2ts6 mice 3.2.1 5 Immunohistochemistry of the thymus in CBA H2tsl mouse 3.2.1 6 Thymic and lymph node T cells in tsA58 transgenic mice 3.2.1 7 Southern blot analysis of TCR jS gene rearrangement in H2ts and TM mice 3.2.1
Load more

Recommended publications
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Beendigung Der Entzündungsreaktion Durch Interleukin-9 Sezernierende
    Beendigung der Entz¨undungsreaktion durch Interleukin-9 sezernierende angeborene Lymphozyten Der Naturwissenschaftlichen Fakult¨at der Friedrich-Alexander-Universit¨at Erlangen-Nurnberg¨ zur Erlangung des Doktorgrades Dr. rer. nat. vorgelegt von Simon Rauber Als Dissertation genehmigt von der Naturwissenschaftlichen Fakult¨at der Friedrich-Alexander-Universit¨at Erlangen-Nurnberg¨ Tag der mundlichen¨ Prufung:¨ 02. 05. 2919 Vorsitzender des Promotionsorgans: Prof. Dr. Georg Kreimer Gutachter: Prof. Dr. Steffen Backert Prof. Dr. Georg Schett Resolution of inflammation by interleukin-9 producing innate lymphoid cells To the Faculty of Natural Sciences of the Friedrich-Alexander-University Erlangen-Nuremberg for the obtainment of the academic degree doctor rerum naturalium (Dr. rer. nat.) submitted by Simon Rauber Approved by the Faculty of Natural Sciences of the Friedrich-Alexander-University Erlangen-Nuremberg Date of oral examination: 02. 05. 2019 Chairman of examination board: Prof. Dr. Georg Kreimer Referees: Prof. Dr. Steffen Backert Prof. Dr. Georg Schett Table of contents 1 Deutsche Kurzfassung1 2 English abstract3 3 Introduction 5 3.1 Innate lymphoid cells and the bridge between primary and adaptive immune response6 3.1.1 The discovery . .7 3.1.2 The classification of innate lymphoid cells and their integration into the im- mune system . 11 3.1.3 Are innate lymphoid cells only innate mirrors or fully-fledged immune cells . 12 3.2 The interleukin-9 . 15 3.2.1 The cellular source of interleukin-9 . 15 3.2.2 The immune-modulatory capacities of interleukin-9 . 17 3.2.2.1 Interleukin-9 in infection, tumour and allergy . 18 3.2.2.2 Interleukin-9 in autoimmune diseases .
    [Show full text]
  • Autoantibody-Mediated Arthritis in The
    Auger et al. Arthritis Research & Therapy 2012, 14:R269 http://arthritis-research.com/content/14/6/R269 RESEARCHARTICLE Open Access Autoantibody-mediated arthritis in the absence of C3 and activating Fcg receptors: C5 is activated by the coagulation cascade Jennifer L Auger1, Stefanie Haasken1,2 and Bryce A Binstadt1* Abstract Introduction: The effector functions of immunoglobulin G (IgG) are mediated by interaction of its Fc region with Fc receptors (FcgRs) and/or the complement system. The three main pathways of complement activation converge at C3. However, C3-independent pathways can activate C5 and other downstream complement components during IgG-initiated inflammatory responses. These C3-independent pathways of C5 activation are triggered by activating FcgRs in some systems or can be activated by factors of the coagulation cascade such as thrombin. Here we studied the interplay of C3, C5, and activating FcgRs in a model of spontaneous autoantibody-driven arthritis. Methods: We utilized the K/BxN TCR transgenic mouse model of arthritis. We bred K/BxN mice bearing targeted or naturally-occurring mutations in one or more of the genes encoding complement components C3, C5, and FcRg, the cytoplasmic signaling chain shared by the activating FcgRs. We measured arthritis development, the production of arthritogenic autoantibodies, T cell activation status and cytokine synthesis. In addition, we treated mice with anti-C5 monoclonal antibodies or with the thrombin inhibitor argatroban. Results: We have previously shown that genetic deficiency of C5 protects K/BxN mice from the development of arthritis. We found here that C3-deficient K/BxN mice developed arthritis equivalent in severity to C3-sufficient animals.
    [Show full text]
  • EMBO Conference Takes to the Sea Life Sciences in Portugal
    SUMMER 2013 ISSUE 24 encounters page 3 page 7 Life sciences in Portugal The limits of privacy page 8 EMBO Conference takes to the sea EDITORIAL Maria Leptin, Director of EMBO, INTERVIEW EMBO Associate Member Tom SPOTLIGHT Read about how the EMBO discusses the San Francisco Declaration Cech shares his views on science in Europe and Courses & Workshops Programme funds on Research Assessment and some of the describes some recent productive collisions. meetings for life scientists in Europe. concerns about Journal Impact Factors. PAGE 2 PAGE 5 PAGE 9 www.embo.org COMMENTARY INSIDE SCIENTIFIC PUBLISHING panels have to evaluate more than a hundred The San Francisco Declaration on applicants to establish a short list for in-depth assessment, they cannot be expected to form their views by reading the original publications Research Assessment of all of the applicants. I believe that the quality of the journal in More than 7000 scientists and 250 science organizations have by now put which research is published can, in principle, their names to a joint statement called the San Francisco Declaration on be used for assessment because it reflects how the expert community who is most competent Research Assessment (DORA; am.ascb.org/dora). The declaration calls to judge it views the science. There has always on the world’s scientific community to avoid misusing the Journal Impact been a prestige factor associated with the publi- Factor in evaluating research for funding, hiring, promotion, or institutional cation of papers in certain journals even before the impact factor existed. This prestige is in many effectiveness.
    [Show full text]
  • CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation Of
    See related commentary on pg 1385 ORIGINAL ARTICLE CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway Mariela Kyoreva1,4, Ying Li1, Mariyah Hoosenally2,5, Jonathan Hardman-Smart2, Kirsten Morrison1,3, Isabella Tosi2, Mauro Tolaini1, Guillermo Barinaga2, Brigitta Stockinger1, Ulrich Mrowietz3, Frank O. Nestle2,6, Catherine H. Smith2, Jonathan N. Barker2 and Paola Di Meglio1,2 The AHR is an environmental sensor and transcription factor activated by a variety of man-made and natural ligands, which has recently emerged as a critical regulator of homeostasis at barrier organs such as the skin. Activation of the AHR pathway downmodulates skin inflammatory responses in animal models and psoriasis clinical samples. In this study, we identify CYP1A1 enzymatic activity as a critical regulator of beneficial AHR signaling in the context of skin inflammation. Mice constitutively expressing Cyp1a1 displayed increased CYP1A1 enzymatic activity in the skin, which resulted in exacerbated immune cell activation and skin pathol- ogy, mirroring that observed in Ahr-deficient mice. Inhibition of CYP1A1 enzymatic activity ameliorated the skin immunopathology by restoring beneficial AHR signaling. Importantly, patients with psoriasis displayed reduced activation of the AHR pathway and increased CYP1A1 enzymatic activity compared with healthy donors, sug- gesting that dysregulation of the AHR/CYP1A1 axis may play a role in inflammatory skin disease. Thus, mod- ulation of CYP1A1 activity may represent a promising alternative strategy to harness the anti-inflammatory effect exerted by activation of the AHR pathway in the skin. Journal of Investigative Dermatology (2021) 141, 1553e1563; doi:10.1016/j.jid.2020.11.024 INTRODUCTION et al., 2014).
    [Show full text]
  • Annual Report 2003
    ANNUAL REPORT 2003 Published by the Marketing and Communications Division The Australian National University Published by The Marketing and Communications Division The Australian National University Produced by ANU Publications Unit Marketing and Communications Division The Australian National University Printed by University Printing Service The Australian National University ISSN 1327-7227 April 2004 Contents Council and University Office rs 7 Review of 2003 10 Council and Council Committee Meetings 20 University Statistics 22 Cooperation with Government and other Public Institutions 30 Joint Research Projects undertaken with Universities, CSIRO and other Institutions 76 Principal Grants and Donations 147 University Public Lectures 168 Freedom of Information Act 1982 Statement 172 Auditor-General’s Report 175 Financial Statements 179 University Organisational Structure 222 Academic Structure 223 ANU Acronyms 224 Index 225 Further information about ANU Detailed information about the achievements of ANU in 2003, especially research and teaching outcomes, is contained in the annual reports of the University’s Research Schools, Faculties, Centres and Administrative Divisions. For course and other academic information, contact: Director Student and Academic Services The Australian National University Canberra ACT 0200 T: 02 6125 3339 F: 02 6125 0751 For general information, contact: Director Marketing and Communications Division The Australian National University Canberra ACT 0200 T: 02 6125 2229 F: 02 6125 5568 The Council and University
    [Show full text]
  • Smutty Alchemy
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2021-01-18 Smutty Alchemy Smith, Mallory E. Land Smith, M. E. L. (2021). Smutty Alchemy (Unpublished doctoral thesis). University of Calgary, Calgary, AB. http://hdl.handle.net/1880/113019 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Smutty Alchemy by Mallory E. Land Smith A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN ENGLISH CALGARY, ALBERTA JANUARY, 2021 © Mallory E. Land Smith 2021 MELS ii Abstract Sina Queyras, in the essay “Lyric Conceptualism: A Manifesto in Progress,” describes the Lyric Conceptualist as a poet capable of recognizing the effects of disparate movements and employing a variety of lyric, conceptual, and language poetry techniques to continue to innovate in poetry without dismissing the work of other schools of poetic thought. Queyras sees the lyric conceptualist as an artistic curator who collects, modifies, selects, synthesizes, and adapts, to create verse that is both conceptual and accessible, using relevant materials and techniques from the past and present. This dissertation responds to Queyras’s idea with a collection of original poems in the lyric conceptualist mode, supported by a critical exegesis of that work.
    [Show full text]
  • Immunology Club Seminar Series 2007 to Present
    Immunology Club Seminar Series 2007-Present Date Seminar Title Speaker Name Speaker Affiliation 1/4/07 Immune Control of HIV: A Perspective from Bruce Walker Harvard Medical School Studies in Africa 1/11/07 Gained in Translation: The Immunoribosome Jon Yewdell NIH Hypothesis of MHC Class I Peptide Generation 1/18/07 Oxidation stress and innate immunity Michael Carroll Harvard Medical School 1/25/07 Identification of the second thymus in mice Hans-Reimer University of Ulm Rodewald 2/1/07 The Sensing and Repair of RAG-induced DNA Barry Sleckman Washington University Double Strand Breaks by ATM School of Medicine, St. Louis 2/8/07 Body traffic -- how enteric microbiota control Jonathan Braun UCLA deployment of enteric regulatory cells 2/15/07 Linking functional stages at the NK cell Jordan Orange University of Pennsylvania cytolytic immunological synapse: insights from human genetic immunodeficiency diseases 2/22/07 Autoantibody-mediated arthritis: another view Diane Mathis Harvard Medical School of organ-targeted autoimmunity 3/1/07 Dissecting interactions between Parasites, P'ng Loke UCSF Macrophages and T cells 3/8/07 Non-histone protein lysine methylation in Alexander (Sasha) Rockefeller University immune system Tarakhovsky 3/15/07 Close Encounters: Th17 and T-reg cells Vijay Kuchroo Harvard Medical School 3/22/07 Functionally activated CD44 in T cell Mark Siegelman University of Texas activation, regulation, and trafficking Southwestern Medical Center 3/29/07 Making pancreatic lymph nodes a dangerous David Serreze Jackson Laboratory
    [Show full text]
  • The Influence of Dendritic Cells on Tolerance Induction to Circulating
    INVOLVEIMN THYMIC NEGA'' ckJL^du'nà oiXAS h\'^(WU 2_ l/\cU ;U it/v +0 cU fcxU iiU 'w ^ J2^r^aH A ^ pn? hex/v^s submitted by ARIANE VOLKMANN for the degree of Doctor of Philosophy University of London Department of Molecular Immunology National Institute for Medical Research London 1996 ProQuest Number: 10018495 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10018495 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 TABLE OF CONTENTS ABSTRACT.................................................................................................................... 5 ACKNOWLED(3EMENTS................................................................................................... 7 ABBREVIATIONS.......................................................................................................... 9 1. INTRODUCTION.....................................................................................................11 1.1 Function of the Immune System ...............................................................................11
    [Show full text]
  • Plasticity of Th17 Cells in Autoimmune Kidney Diseases Christian F
    Plasticity of Th17 Cells in Autoimmune Kidney Diseases Christian F. Krebs, Jan-Eric Turner, Hans-Joachim Paust, Sonja Kapffer, Tobias Koyro, Sonja Krohn, Friederike Ufer, This information is current as Manuel A. Friese, Richard A. Flavell, Brigitta Stockinger, of October 2, 2021. Oliver M. Steinmetz, Rolf A. K. Stahl, Samuel Huber and Ulf Panzer J Immunol 2016; 197:449-457; Prepublished online 6 June 2016; doi: 10.4049/jimmunol.1501831 Downloaded from http://www.jimmunol.org/content/197/2/449 Supplementary http://www.jimmunol.org/content/suppl/2016/06/04/jimmunol.150183 http://www.jimmunol.org/ Material 1.DCSupplemental References This article cites 35 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/197/2/449.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 2, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Plasticity of Th17 Cells in Autoimmune Kidney Diseases Christian F.
    [Show full text]
  • Acknowledgment of Reviewers, 2009
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2009 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2009. Their generous contribution is deeply appreciated. A R. Alison Adcock Schahram Akbarian Paul Allen Lauren Ancel Meyers Duur Aanen Lia Addadi Brian Akerley Phillip Allen Robin Anders Lucien Aarden John Adelman Joshua Akey Fred Allendorf Jens Andersen Ruben Abagayan Zach Adelman Anna Akhmanova Robert Aller Olaf Andersen Alejandro Aballay Sarah Ades Eduard Akhunov Thorsten Allers Richard Andersen Cory Abate-Shen Stuart B. Adler Huda Akil Stefano Allesina Robert Andersen Abul Abbas Ralph Adolphs Shizuo Akira Richard Alley Adam Anderson Jonathan Abbatt Markus Aebi Gustav Akk Mark Alliegro Daniel Anderson Patrick Abbot Ueli Aebi Mikael Akke David Allison David Anderson Geoffrey Abbott Peter Aerts Armen Akopian Jeremy Allison Deborah Anderson L. Abbott Markus Affolter David Alais John Allman Gary Anderson Larry Abbott Pavel Afonine Eric Alani Laura Almasy James Anderson Akio Abe Jeffrey Agar Balbino Alarcon Osborne Almeida John Anderson Stephen Abedon Bharat Aggarwal McEwan Alastair Grac¸a Almeida-Porada Kathryn Anderson Steffen Abel John Aggleton Mikko Alava Genevieve Almouzni Mark Anderson Eugene Agichtein Christopher Albanese Emad Alnemri Richard Anderson Ted Abel Xabier Agirrezabala Birgit Alber Costica Aloman Robert P. Anderson Asa Abeliovich Ariel Agmon Tom Alber Jose´ Alonso Timothy Anderson Birgit Abler Noe¨l Agne`s Mark Albers Carlos Alonso-Alvarez Inger Andersson Robert Abraham Vladimir Agranovich Matthew Albert Suzanne Alonzo Tommy Andersson Wickliffe Abraham Anurag Agrawal Kurt Albertine Carlos Alos-Ferrer Masami Ando Charles Abrams Arun Agrawal Susan Alberts Seth Alper Tadashi Andoh Peter Abrams Rajendra Agrawal Adriana Albini Margaret Altemus Jose Andrade, Jr.
    [Show full text]
  • Targeting the Terminal Pathway in Complement – Driven Disease
    Targeting the Terminal Pathway in Complement – Driven Disease. Wioleta Milena Zelek A thesis submitted to Cardiff University in candidature for the degree of Doctor of Philosophy. September 2019 1 Choose a job you love, and you will never have to work a day in your life. - Confucius 1 2 ACKNOWLEDGEMENTS; I would like to express my deepest thanks to the following people: • My primary supervisor Professor Paul Morgan for taking me on a journey of Complement, for his encouragement, direction and much appreciated motivating discussions throughout my PhD, all the inspiring quotes such as; “it’s only impossible until someone does it” “an expert is someone who knows almost everything about almost nothing” “…you answered one question, now there are two more to ask” “choose your battles!” • My PhD co-supervisor Professor Philip Taylor, for his inspiring comments. • Professor Claire Harris for her much valued advice, and extensive expertise during the SPR analysis, for her encouragement and ongoing support. • My PhD Annual Review panel for valuable feedback during the course of this study. • Collaborators for providing crucial reagents for this project; F. Hoffmann-La Roche Ltd., Complement Pharma, GSK, David Kavanagh and Brigitta Stockinger. • Grant Funders; Welsh Government and Life Science Research Network in Wales (LSRN) for supporting this work, LSRN Translational Support Fund for sequencing the antibodies developed and Systems Immunity Research Institute for funds to visit Monash University. • Travel award funders (British Society of Immunology and WM Thomas Fund) and conference organisers (Complement UK, ICW, EMCHD, BSI and I&I) for all the opportunities to present my data.
    [Show full text]